ERBB2 and cervical cancer: For the small number of HPV-negative cervical cancers, over-activation of the PI3K/AKT/mTOR pathway or mutations of its regulatory factors, such as PTEN, EGFR, and HER2, accounted for the virus-independent etiology of carcinogenesis (Tjalma, 2018).